Stay updated with breaking news from Nasdaq Atha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Athira Pharma (NASDAQ:ATHA – Get Rating) issued its quarterly earnings results on Thursday. The company reported ($0.56) EPS for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.01), MarketWatch Earnings reports. NASDAQ ATHA opened at $8.28 on Friday. Athira Pharma has a 52-week low of $7.56 and a 52-week high of $23.64. The company […]
Athira Pharma (NASDAQ:ATHA – Get Rating) announced its quarterly earnings results on Thursday. The company reported ($0.56) earnings per share for the quarter, missing the consensus estimate of ($0.55) by ($0.01), MarketWatch Earnings reports. Shares of Athira Pharma stock opened at $8.28 on Friday. Athira Pharma has a 1 year low of $7.56 and a […]
Athira Urges Shareholders to Vote “FOR” Athira’s Highly Qualified, Independent Director Nominees – Joseph Edelman, John M. Fluke, Jr. and Grant Pickering –...
Urges shareholders to vote “FOR” Athira’s highly qualified, independent director nominees – Joseph Edelman, John M. Fluke, Jr. and Grant Pickering – on the...
Athira Pharma (NASDAQ:ATHA – Get Rating)‘s stock had its “buy” rating reiterated by stock analysts at JMP Securities in a research report issued to clients and investors on Friday, TipRanks reports. They currently have a $51.00 price objective on the stock. JMP Securities’ price target indicates a potential upside of 300.31% from the stock’s current […]